Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Randomized Controlled Trial
. 2005;20(1):6-10.
doi: 10.1007/s10103-005-0330-5. Epub 2005 May 21.

A Single-Blinded Randomised Controlled Study to Determine the Efficacy of Omnilux Revive Facial Treatment in Skin Rejuvenation

Affiliations
Randomized Controlled Trial

A Single-Blinded Randomised Controlled Study to Determine the Efficacy of Omnilux Revive Facial Treatment in Skin Rejuvenation

Jaideep Bhat et al. Lasers Med Sci. .

Abstract

To determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation, twenty-three volunteers received randomised 20 min treatments three times a week for three weeks to one half of their face, with the untreated side acting as control. Regular assessments were carried out, focusing on parameters of subject satisfaction, photographic assessments, skin elasticity (Cutometer) and skin hydration (Corneometer CM825). Ninety-one percent of the volunteers reported visible changes to their skin. Blinded photographic evaluation reported a clinical response in 59% of the subjects. Objective analysis failed to show statistically significant changes in skin hydration or elasticity. The Omnilux Revive LED lamp is a safe alternative non-ablative skin rejuvenation treatment.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Br J Plast Surg. 1995 Sep;48(6):360-70 - PubMed
    1. Arch Dermatol. 2002 Nov;138(11):1503-8 - PubMed
    1. Lasers Surg Med. 1989;9(5):497-505 - PubMed
    1. Dermatol Surg. 2002 Aug;28(8):742-4; discussion 744 - PubMed
    1. Dermatol Surg. 2000 Sep;26(9):835-42; discussion 843 - PubMed

Publication types

Substances

LinkOut - more resources

Feedback